• Lantern Pharma Launches ZetaOmics, an AI-Powered Computational Biology Platform citybuzz - Wed, 08 Jul 2026 16:29:57 GMT
• Lantern Pharma launches ZetaOmics computational-biology module TipRanks Wed, 08 Jul 2026 12:38:52 GMT
• Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent "Computational Biologist" That Brings Expert-Grade Bioinformatics,... Yahoo Finance UK Wed, 08 Jul 2026 11:30:00 GMT
• lantern pharma and starlight therapeutics announce fda clearance The National Law Review Tue, 30 Jun 2026 12:28:29 GMT
• ltrn q1 2026 earnings: narrower-than-expected loss drives positive surprise - consensus beat rate dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• lantern pharma inc (ltrn) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 03:29:45 GMT
• lantern pharma inc (ltrn) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 01:25:55 GMT
• lantern pharma inc (ltrn) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 01:22:24 GMT
• lantern pharma inc (ltrn) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 01:22:14 GMT
• lantern pharma inc (ltrn) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 01:21:03 GMT
• lantern pharma inc (ltrn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 18:04:48 GMT
• lantern pharma inc (ltrn) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 17:56:26 GMT
• lantern pharma inc (ltrn) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 17:56:25 GMT
• Lantern Pharma’s Dramatic Slide Reflects Key Strategic Uncertainties timothysykes.com Mon, 15 Jun 2026 07:00:00 GMT
• lantern pharma (ltrn) faces pressure: shares dip 4.67% as technical support at $3.69 looms - continuation pattern picks newsline.com Mon, 15 Jun 2026 01:38:17 GMT
• Lantern Pharma (NASDAQ: LTRN) files S-1 resale and flags funding risk Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Lantern Pharma (LTRN) Falls 4.7% as Biotech Stock Tests Key Support Zone - Post-Earnings Moves dars.gov.et Fri, 12 Jun 2026 07:00:00 GMT
• lantern pharma announced that its candidate drug lp-300 has achieved significant interim data results in a study targeting non-sma... Bitget Tue, 02 Jun 2026 13:55:26 GMT
• Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exo... Business Wire Tue, 02 Jun 2026 07:00:00 GMT
• Lantern Pharma (LTRN) shares Harmonic LP-300 Phase 2 trial presentation in 8-K Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• Lantern Pharma stock jumps on lung cancer trial survival data Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Lantern Pharma (LTRN) Shares Promising Phase 2 Trial Results GuruFocus Tue, 02 Jun 2026 07:00:00 GMT
• Lantern Pharma reports trial data for lung cancer treatment Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• lantern pharma inc. (ltrn) q1 2026 earnings: narrower-than-expected loss lifts stock - profit cycle analysis dars.gov.et Tue, 02 Jun 2026 07:00:00 GMT
• lantern pharma reports harmonic data showing lp-300 progression-free survival benefit deepens with treatment duration in egfr exon... TradingView Tue, 02 Jun 2026 07:00:00 GMT
• lantern pharma announced that its candidate drug lp-300 has achieved significant interim data results in a study targeting non-sma... Bitget Mon, 01 Jun 2026 21:21:37 GMT
• lantern pharma (ltrn) shares harmonic lp-300 phase 2 trial presentation in 8-k Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• ltrn q1 2026 earnings: eps beat expectations as biotech focuses on pipeline progress - analyst drop coverage Město Břeclav Thu, 28 May 2026 07:00:00 GMT
• ltrn technical analysis | trend, signals & chart patterns | lantern pharma inc (nasdaq:ltrn) ChartMill Wed, 27 May 2026 07:00:00 GMT
• lantern pharma announces $9.25 million registered direct offering geneonline.com Tue, 26 May 2026 21:58:06 GMT
• ltrn technical analysis | trend, signals & chart patterns | lantern pharma inc (nasdaq:ltrn) ChartMill Tue, 26 May 2026 07:00:00 GMT
• Lantern Pharma (LTRN) Q1 2025 Earnings Transcript The Globe and Mail Thu, 21 May 2026 07:00:00 GMT
• lantern pharma (ltrn) receives fda support for phase 2 trial GuruFocus Tue, 19 May 2026 13:41:15 GMT
• lantern receives successful response to type c meeting from fda on lp-300 TipRanks Tue, 19 May 2026 12:08:30 GMT
• fda lets lung cancer trial focus on never-smokers with egfr exon 21 l858r Stock Titan Tue, 19 May 2026 11:30:00 GMT
• Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC™ Phase 2 Trial of LP-300 in Never-Smokers w... Business Wire Tue, 19 May 2026 07:00:00 GMT
• lantern pharma receives fda clearance for trial amendments by investing.com Investing.com Canada Tue, 19 May 2026 07:00:00 GMT
• lantern pharma reports first quarter 2026 financial results and provides business updates BioSpace Mon, 18 May 2026 01:55:46 GMT
• lantern pharma reports first quarter 2026 financial results and provides business updates BioSpace Sun, 17 May 2026 07:00:00 GMT
• lantern pharma (ltrn) q1 2026: eps -$0.30 beats est. -$0.36; rev GuruFocus Sat, 16 May 2026 05:48:11 GMT
• lantern pharma inc (ltrn) stock price, quote, news & history Benzinga Fri, 15 May 2026 23:51:00 GMT
• lantern pharma (nasdaq: ltrn) cuts r&d, advances oncology pipeline and ai spin-out Stock Titan Fri, 15 May 2026 20:07:33 GMT
• lantern pharma inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 15 May 2026 20:06:00 GMT
• Lantern Pharma Reports First Quarter 2026 Financial Results and Provides Business Updates Business Wire Fri, 15 May 2026 07:00:00 GMT
• LANTERN PHARMA ($LTRN) Releases Q1 2026 Earnings Quiver Quantitative Fri, 15 May 2026 07:00:00 GMT
• Lantern Pharma Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Fri, 15 May 2026 07:00:00 GMT
• Lantern Pharma Announces $9.25 Million Registered Direct Offering and Plans for Independent AI Entity with withZeta.ai 1 – Minicha... Minichart Fri, 15 May 2026 07:00:00 GMT
• lantern pharma (nasdaq: ltrn) raises $4.4m and plans withzeta.ai spinout Stock Titan Fri, 15 May 2026 07:00:00 GMT
• lantern pharma ($ltrn) releases q1 2026 earnings | ltrn stock news Quiver Quantitative Fri, 15 May 2026 07:00:00 GMT
• lantern pharma (ltrn) q1 2026: eps -$0.30 beats est. -$0.36; rev GuruFocus Fri, 15 May 2026 07:00:00 GMT
• bios funds report 4.48% lantern pharma (nasdaq: ltrn) stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• lantern pharma closes $4.4m registered direct offering by investing.com Investing.com Australia Fri, 15 May 2026 07:00:00 GMT
• insider buying: lee schalop acquires 48,544 shares of lantern ph GuruFocus Fri, 15 May 2026 04:48:36 GMT
• lantern pharma directors make bold insider moves that investors can’t ignore TipRanks Fri, 15 May 2026 02:21:08 GMT
• financialcontent - lantern pharma inc. announces closing of up to $9.25 million registered direct offering with existing holders a... FinancialContent Thu, 14 May 2026 20:05:00 GMT
• ai oncology firm lantern pharma lines up up to $9.25m with warrant deal Stock Titan Thu, 14 May 2026 20:05:00 GMT
• Lantern Pharma Inc. Announces Closing of up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institu... Business Wire Thu, 14 May 2026 07:00:00 GMT
• Lantern Pharma (NASDAQ: LTRN) closes $4.4M offering and outlines AI spin-out Stock Titan Thu, 14 May 2026 07:00:00 GMT
• Lantern Pharma closes $4.4M registered direct offering Investing.com Thu, 14 May 2026 07:00:00 GMT
• Lantern Pharma (LTRN) director buys shares and long-dated warrants Stock Titan Thu, 14 May 2026 07:00:00 GMT
• Lantern Pharma (LTRN) director adds shares and long-dated stock warrants Stock Titan Thu, 14 May 2026 07:00:00 GMT
• Insider Buying: Lee Schalop Acquires 48,544 Shares of Lantern Ph GuruFocus Thu, 14 May 2026 07:00:00 GMT
• lantern pharma raises $4.4 million in registered direct, adds private warrants; engages rodman and renshaw TradingView Thu, 14 May 2026 07:00:00 GMT
• lantern pharma (nasdaq: ltrn) sells 1.45m shares, pre-funded warrants included Stock Titan Thu, 14 May 2026 07:00:00 GMT
• lantern pharma reports first quarter 2026 financial results and provides business updates Business Wire Thu, 14 May 2026 07:00:00 GMT
• lantern pharma inc. announces up to $9.25 million registered direct offering with existing holders and a single institutional inve... BioSpace Thu, 14 May 2026 04:19:09 GMT
• lantern pharma prices 2.14m shares at $2.06 in registered direct offering TipRanks Wed, 13 May 2026 16:51:30 GMT
• ai cancer firm lantern pharma lines up $4.4m, plans withzeta.ai spin-off Stock Titan Wed, 13 May 2026 12:00:00 GMT
• Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Inve... Business Wire Wed, 13 May 2026 07:00:00 GMT
• Lantern Pharma raises $4.4M in registered direct offering Investing.com Wed, 13 May 2026 07:00:00 GMT
• lantern pharma inc expected to post a loss of 36 cents a share - earnings preview TradingView Wed, 13 May 2026 07:00:00 GMT
• lantern pharma to report first quarter 2026 operating & financial results on may 15th, 2026 BioSpace Tue, 12 May 2026 06:52:07 GMT
• lantern pharma (ltrn.us) will release its earnings report after the market closes on may 15. 富途牛牛 Tue, 12 May 2026 00:53:32 GMT
• lantern pharma (ltrn.us) will release its earnings report after the market closes on may 15. Moomoo Mon, 11 May 2026 23:00:19 GMT
• lantern pharma q1 2026 financial results to be released may 15th geneonline.com Mon, 11 May 2026 21:38:56 GMT
• Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026 Business Wire Mon, 11 May 2026 07:00:00 GMT
• Press Release: Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026 Moomoo Mon, 11 May 2026 07:00:00 GMT
• top pre-market gainers today — elab, itrm, ltrn among stocks soaring before the bell MSN Fri, 08 May 2026 01:39:19 GMT
• Lantern Pharma Unveils Roadmap for withZeta.ai — Industry-First, Multi-Agentic Co-Scientist Featuring Swarm Intelligence and Compu... Business Wire Thu, 07 May 2026 07:00:00 GMT
• lantern starts selling its oncology ai platform, maps swarm upgrade Stock Titan Thu, 07 May 2026 07:00:00 GMT
• lantern pharma inc. unveils roadmap for withzeta.ai with launch of zetaswarm and zetaomics marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• lantern pharma launches withzeta.ai platform featuring zetaswarm™ and zetaomics™ for enhanced drug discovery geneonline.com Thu, 07 May 2026 07:00:00 GMT
• lantern pharma (nasdaq: ltrn) details pay, ownership, options Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• lantern pharma inc. 2025 annual report amendment – executive compensation, corporate governance, and audit committee details Minichart Thu, 30 Apr 2026 07:00:00 GMT
• lantern receives fda clearance for paediatric star-001 cns trial MSN Thu, 30 Apr 2026 04:01:57 GMT
• lantern pharma (ltrn) introduces advanced molecular intelligence platform GuruFocus Wed, 29 Apr 2026 15:14:46 GMT
• Lantern Pharma’s predictBBB.ai Evolves Into a Real-Time Large Quantitative Model (LQM) for Precision Molecular Intelligence — Comp... Business Wire Wed, 29 Apr 2026 07:00:00 GMT
• lantern pharma expands predictbbb platform into large quantitative model for drug discovery MEXC Wed, 29 Apr 2026 07:00:00 GMT
• type one molecule string, get 99 drug design metrics in seconds Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• lantern pharma announces expansion of predictbbb.ai into lqm TipRanks Wed, 29 Apr 2026 07:00:00 GMT
• lantern pharma inc (ltrn) stock price & 30 year financial data GuruFocus Mon, 27 Apr 2026 14:15:02 GMT
• ltrn stock gains 18% pre-market: fda greenlights first pediatric cancer trial for ai-driven drug MSN Mon, 27 Apr 2026 07:48:29 GMT
• lantern receives fda clearance for paediatric star-001 cns trial MSN Mon, 27 Apr 2026 02:17:35 GMT
• top pre-market gainers today — elab, itrm, ltrn among stocks soaring before the bell MSN Mon, 27 Apr 2026 01:56:47 GMT
• ltrn stock gains 18% pre-market: fda greenlights first pediatric cancer trial for ai-driven drug MSN Sun, 26 Apr 2026 11:03:45 GMT
• lantern receives fda clearance for paediatric star-001 cns trial MSN Sun, 26 Apr 2026 02:55:32 GMT
• ltrn stock gains 18% pre-market: fda greenlights first pediatric cancer trial for ai-driven drug MSN Sat, 25 Apr 2026 19:26:41 GMT
• new to the street broadcasts show #746 tonight on bloomberg television 6:30pm est featuring nrx pharma (nasdaq:nrxp), performance ... newswire.com Sat, 25 Apr 2026 07:00:00 GMT
• lantern receives fda clearance for paediatric star-001 cns trial MSN Fri, 24 Apr 2026 23:24:36 GMT
• lantern pharma inc. debuts public demonstration of withzeta.ai platform marketscreener.com Fri, 24 Apr 2026 11:50:00 GMT
• ltrn stock gains 18% pre-market: fda greenlights first pediatric cancer trial for ai-driven drug MSN Fri, 24 Apr 2026 10:16:36 GMT
• Lantern Pharma to Debut Public Demonstration of withZeta.ai - A Platform to Conquer Rare Cancers on April 30 Following AACR 2026 S... Business Wire Fri, 24 Apr 2026 07:00:00 GMT
• correction: join lantern pharma on april 30 for the first public demonstration of withzeta.ai - a platform to conquer rare cancers... ACCESS Newswire Fri, 24 Apr 2026 07:00:00 GMT
• daily penny alerts - lantern pharma to debut public demonstration of withzeta.ai - a platform to conquer rare cancers on april 30 ... FinancialContent Fri, 24 Apr 2026 07:00:00 GMT
• rare-cancer ai platform opens to the public in live apr. 30 demo Stock Titan Fri, 24 Apr 2026 07:00:00 GMT
• join lantern pharma on april 30 for the first public demonstration of with zeta.ai - a platform to conquer rare cancers ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• lantern pharma announces public demonstration of withzeta.ai TipRanks Fri, 24 Apr 2026 07:00:00 GMT
• top pre-market gainers today — elab, itrm, ltrn among stocks soaring before the bell MSN Thu, 23 Apr 2026 11:13:52 GMT
• lantern pharma outlines $15b–$20b market potential as ai-driven pipeline advances and funding needs intensify MSN Thu, 23 Apr 2026 10:05:51 GMT
• lake street maintains lantern pharma(ltrn.us) with buy rating, maintains target price $25 富途牛牛 Wed, 22 Apr 2026 01:43:51 GMT
• lantern pharma schedules type c meeting with fda for phase 2 harmonic trial TipRanks Tue, 21 Apr 2026 07:30:00 GMT
• lake street maintains lantern pharma(ltrn.us) with buy rating, maintains target price $25 Moomoo Tue, 21 Apr 2026 07:00:00 GMT
• lantern pharma (ltrn) plans fda meeting for trial protocol adjus GuruFocus Mon, 20 Apr 2026 18:33:45 GMT
• Emerging Data for Lantern Pharma’s Investigational Drug LP-300 Demonstrates 8.3-Month Median Progression-Free Survival in Patients... Business Wire Mon, 20 Apr 2026 07:00:00 GMT
• lantern pharma schedules fda meeting on lung cancer trial changes Investing.com Mon, 20 Apr 2026 07:00:00 GMT
• lantern pharma inc - schedules type c fda meeting for harmonic protocol amendments TradingView Mon, 20 Apr 2026 07:00:00 GMT
• lantern pharma schedules type c meeting with fda for phase 2 harmonic trial TipRanks Mon, 20 Apr 2026 07:00:00 GMT
• lantern pharma launches withzeta.ai — the world’s first multi-agentic a.i. co-scientist for rare cancer drug discovery & developme... ChartMill Mon, 20 Apr 2026 04:10:24 GMT
• lantern pharma (ltrn) stock: technical chart (risk aversion) 2026-04-18 - most discussed stocks Cổng thông tin điện tử tỉnh Lào Cai Sat, 18 Apr 2026 23:25:49 GMT
• lantern receives fda clearance for paediatric star-001 cns trial MSN Sat, 18 Apr 2026 22:06:24 GMT
• is lantern pharma (ltrn) stock gaining momentum (weakens) 2026-04-18 - stock trading network Cổng thông tin điện tử tỉnh Lào Cai Sat, 18 Apr 2026 12:25:18 GMT
• lantern receives fda clearance for paediatric star-001 cns trial MSN Fri, 17 Apr 2026 12:35:39 GMT
• lantern pharma reports third quarter 2023 financial results and operational highlights ADVFN Thu, 16 Apr 2026 19:02:52 GMT
• funds report 834,752 lantern pharma (ltrn) shares in ownership update Stock Titan Thu, 16 Apr 2026 07:00:00 GMT
• ltrn: ai-driven cancer drug development platform advances clinical pipeline and opens new market opportunities TradingView Thu, 16 Apr 2026 07:00:00 GMT
• lantern pharma provides business updates and fourth quarter & year-end 2024 financial results ADVFN Thu, 16 Apr 2026 05:42:48 GMT
Lantern Pharma Inc(NASDAQ:LTRN) 
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on the development of precision oncology therapies using artificial intelligence, genomics, and machine learning. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant...
Website: http://www.lanternpharma.com
Founded: 2013
Full Time Employees: 4
CEO: Panna L. Sharma
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends